Vir Biotechnology, Inc. VIR Total costs & expenses
Total costs & expenses at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CostsAndExpenses.
The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vir Biotechnology, Inc.'s total costs & expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vir Biotechnology, Inc.'s total costs & expenses?
- Vir Biotechnology, Inc. (VIR) reported total costs & expenses of $132.26M in Q1 2026.
- How has Vir Biotechnology, Inc.'s total costs & expenses changed year-over-year?
- Vir Biotechnology, Inc.'s total costs & expenses decreased by 7.2% year-over-year, from $142.58M to $132.26M.
- What is the long-term trend for Vir Biotechnology, Inc.'s total costs & expenses?
- Over 4 years (2021 to 2025), Vir Biotechnology, Inc.'s total costs & expenses has grown at a -5.1% compound annual growth rate (CAGR), from $674.66M to $547.88M.
- What does total costs & expenses mean?
- This metric aggregates all operating and non-operating costs incurred by the company to support its business activities, including research and development, selling, general, and administrative expenses. It serves as a comprehensive measure of the total capital required to maintain operations and advance the product pipeline. Analyzing this figure helps stakeholders evaluate the company's overall cost structure and operational burn rate.